Molecular mediators of liver ischemia and reperfusion injury: A brief review

Molecular Medicine

Volumn 14, Issue 5-6, 2008, Pages 337-345

  Vardanian, Andrew J ^a   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^a,b  

^a UCLA MEDICAL CENTER   (United States)

^b MC 705418 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; ACETYLCYSTEINE; GABEXATE MESILATE; HEME OXYGENASE; METHYLPREDNISOLONE; NITRIC OXIDE; OXYGEN RADICAL; TACROLIMUS; THYMOCYTE ANTIBODY; TOLL LIKE RECEPTOR;

CLINICAL TRIAL; GENE EXPRESSION; HUMAN; LEUKOCYTE; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SHORT SURVEY;

ANIMALS; HUMANS; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REPERFUSION INJURY;

EID: 44649117021     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00134.Vardanian     Document Type: Short Survey

References (122)

1. Yellon DM, Hausenloy DJ. (2007) Myocardial reperfusion injury. N. Engl. J. Med. 357:1121-35.
2. Land W, et al. (1994) The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57:211-7.
3. Land WG. (2005) The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79:505-14.
4. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. (2003) Hepatic ischemia/reperfusion injury: a fresh look. Exp. Mol. Pathol. 74:86-93.
5. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Herman B. (1997) The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol. Cell. Biochem. 174:159-65.
6. Belzer FO, Southard JH. (1988) Principles of solid-organ preservation by cold storage. Transplantation 45:673-6.
7. Takeda K, Kaisho T, Akira S. (2003) Toll-like receptors. Ann. Rev. Immunol. 21:335-76.
8. Hopkins PA, Sriskandan S. (2005) Mammalian Toll-like receptors: to immunity and beyond. Clin. Exp. Immunol. 140:395-407.
9. Tsan MF, Gao B. (2004) Endogenous ligands of Toll-like receptors. J. Leukocyte Biol. 76:514-9.
10. Foell D, Wittkowski H, Roth J. (2007) Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3:382-90.
11. Roelofs MF, et al. (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J. Immunol. 176:7021-7.
12. Ohashi K, Burkart V, Flohe S, Kolb H. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:558-61.
13. Levy RM, et al. (2007) Systemic inflammation and remote organ injury following trauma require HMGB1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R1538-44.
14. Figueiredo RT, et al. (2007) Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282:20221-9.
15. Zhai Y, Qiao B SH, Gao F, Busuttil RW, Cheng G, Platt JL, Volk HD, Kupiec-Weglinski JW. Evidence for the pivotal role of endogenous TLR4 ligands in liver ischemia and reperfusion injury. Transplantation (In Press).
16. Zhai Y, et al. (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173:7115-9.
17. Tsung A, et al. (2005) Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in non-parenchymal cells. J. Immunol. 175:7661-8.
18. Aprahamian CJ, Lorenz RG, Harmon CM, Dimmit RA. (2008) Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr. Crit. Care Med. 9:105-9.
19. Leemans JC, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115:2894-903.
20. Shigeoka AA, et al. (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178:6252-8.
21. Wu H, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117:2847-59.
22. Oyama J, et al. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109:784-9.
23. Kim SC, et al. (2007) Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function. BMC Physiol. 7:5.
24. Hua F, et al. (2007) Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 178:7317-24.
25. Hua F, et al. (2005) Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts. Biochem. Biophys. Res. Commun. 338:1118-25.
26. Jaeschke H, Farhood A. (1991) Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 260:G355-62.
27. Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA. (1996) Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol. Appl. Pharmacol. 139:213-26.
28. Jaeschke H. (2002) Reperfusion injury after warm ischemia or cold storage of the liver: role of apoptotic cell death. Transplant. Proc. 34:2656-8.
29. Poli G, Cutrin JC, Biasi F. (1998) Lipid peroxidation in the reperfusion injury of the liver. Free Radic. Res. 28:547-51.
30. Jaeschke H. (2000) Reactive oxygen and mechanisms of inflammatory liver injury. J. Gastroenterol. Hepatol. 15:718-24.
31. Szabo C, Ischiropoulos H, Radi R. (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6:662-80.
32. Yuzawa H, et al. (2005) Inhibitory effects of safe and novel SOD derivatives, galactosylated-SOD, on hepatic warm ischemia/reperfusion injury in pigs. Hepatogastroenterology 52:839-43.
33. Mizoe A, et al. (1997) Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation. J. Surg. Res. 73:160-5.
34. Ejiri S, Eguchi Y, Kishida A, Kurumi Y, Tani T, Kodama M. (2000) Protective effect of OPC-6535, a superoxide anion production inhibitor, on liver grafts subjected to warm ischemia during porcine liver transplantation. Transplant Proc. 32:318-21.
35. He SQ, et al. (2006) Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl. 12:1869-79.
36. Lehmann TG, et al. (2000) Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat. Hepatology (Baltimore) 32:1255-64.
37. Wu TJ, Khoo NH, Zhou F, Day BJ, Parks DA. (2007) Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes. Free Radic. Res. 41:127-34.
38. Dulundu E, et al. (2007) Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats. Pharmacology 79:163-70.
39. Abe T, et al. (2004) A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. J. Gastrointest. Surg. 8:604-15.
40. Ninomiya M, Shimada M, Harada N, Soejima Y, Suehiro T, Maehara Y. (2004) The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury. Br. J. Surg. 91:184-90.
41. Ninomiya M, et al. (2002) Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. Transplantation 74:1470-2.
42. Sepodes B, et al. (2004) Tempol, an intracellular free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant. Proc. 36:849-53.
43. Yokota R, et al. (2000) A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery 127:661-9.
44. Moncada S, Higgs A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-12.
45. Mocellin S, Bronte V, Nitti D. (2007) Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27:317-52.
46. Bogdan C. (2001) Nitric oxide and the immune response. Nat. Immunol. 2:907-16.
47. Hara Y, Teramoto K, Ishidate K, Arii S. (2006) Cytoprotective function of tetrahydrobiopterin in rat liver ischemia/reperfusion injury. Surgery 139:377-84.
48. Hara Y, et al. (2005) Beneficial effect of tetrahydrobiopterin on the survival of rats exposed to hepatic ischemia-reperfusion injury. Transplant. Proc. 37:442-4.
49. Kaizu T, et al. (2006) Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology (Baltimore) 43:464-73.
50. Hines IN, Harada H, Flores S, Gao B, McCord JM, Grisham MB. (2005) Endothelial nitric oxide synthase protects the post-ischemic liver: potential interactions with superoxide. Biomed. Pharmacother. 59:183-9.
51. Varadarajan R, et al. (2004) Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation. Transplantation 78:250-6.
52. Theruvath TP, Zhong Z, Currin RT, Ramshesh VK, Lemasters JJ. (2006) Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: role of vasodilatory and innate immunity pathways. Transplant. Proc. 38:3351-7.
53. Duranski MR, Elrod JW, Calvert JW, Bryan NS, Feelisch M, Lefer DJ. (2006) Genetic overexpression of eNOS attenuates hepatic ischemiareperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 291:H2980-6.
54. Schwentker A, Billiar TR. (2002) Inducible nitric oxide synthase: from cloning to therapeutic applications. World J. Surg. 26:772-8.
55. Liu P, Xu B, Quilley J, Wong PY. (2000) Peroxynitrite attenuates hepatic ischemia-reperfusion injury. Am. J. Physiol. Cell Physiol. 279:C1970-7.
56. Kimura H, et al. (2003) Role of inducible nitric oxide synthase in pig liver transplantation. J. Surg. Res. 111:28-37.
57. Koeppel TA, et al. (2007) Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur. Surg. Res. 39:303-11.
58. Tsuchihashi S, et al. (2006) FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am. J. Transplant. 6:2013-22.
59. Meguro M, et al. (2002) A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 73:1439-46.
60. Shiva S, et al. (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204:2089-102.
61. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. (2002) Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology (Baltimore) 36:573-81.
62. Geller DA, Chia SH, Takahashi Y, Yagnik GP, Tsoulfas G, Murase N. (2001) Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. JPEN J. Parenter. Enteral Nutr. 25:142-7.
63. Reid KM, et al. (2007) Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am. J. Physiol. 292:G512-7.
64. Maines MD. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517-54.
65. Amersi F, et al. (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104:1631-9.
66. Kato H, et al. (2001) Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am. J. Transplant. 1:121-8.
67. Tsuchihashi S, Zhai Y, Bo Q, Busuttil RW, Kupiec-Weglinski JW. (2007) Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation 83:1628-34.
68. Coito AJ, et al. (2002) Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74:96-102.
69. Ke B, et al. (2002) Heme oxygenase-1 gene transfer prevents CD95/FasL-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Transplant. Proc. 34:1465-6.
70. Ke B, et al. (2002) Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum. Gene Ther. 13:1189-99.
71. Tsuchihashi S, Livhits M, Zhai Y, Busuttil RW, Araujo JA, Kupiec-Weglinski JW. (2006) Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection. J. Immunol. 177:4749-57.
72. Schmidt R, et al. (2007) Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann. Surg. 245:931-42.
73. Fondevila C, et al. (2004) Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology (Baltimore) 40:1333-41.
74. Fondevila C, et al. (2003) Biliverdin protects rat livers from ischemia/reperfusion injury. Transplant. Proc. 35:1798-9.
75. Kato Y, et al. (2003) Bilirubin rinse: a simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioning. Hepatology (Baltimore) 38:364-73.
76. Tang LM, et al. (2007) Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts. Transplant. Proc. 39:1338-44.
77. Kaizu T, et al. (2005) Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 138:229-35.
78. Amersi F, et al. (2002) Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology (Baltimore) 35:815-23.
79. Racanelli V, Rehermann B. (2006) The liver as an immunological organ. Hepatology (Baltimore) 43:S54-62.
80. Caldwell CC, Tschoep J, Lentsch AB. (2007) Lymphocyte function during hepatic ischemia/reperfusion injury. J. Leukocyte Biol. 82:457-64.
81. Huang Y, Rabb H, Womer KL. (2007) Ischemia-reperfusion and immediate T cell responses. Cell. Immunol. 248:4-11.
82. Vachino G, et al. (1995) P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J. Biol. Chem. 270:21966-74.
83. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. (1999) P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology (Baltimore) 29:1494-502.
84. Tsuchihashi S, et al. (2006) Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantation. J. Immunol. 176:616-24.
85. Amersi F, et al. (2002) P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury. Am. J. Transplant. 2:600-8.
86. Amersi F, et al. (2001) A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation 71:112-8.
87. Dulkanchainun TS, et al. (1998) Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann. Surg. 227:832-40.
88. Fuller TF, Sattler B, Binder L, Vetterlein F, Ringe B, Lorf T. (2001) Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand. Transplantation 72:216-22.
89. Singbartl K, Green SA, Ley K. (2000) Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J. 14:48-54.
90. Farmer DG, et al. (2002) Improved survival through the reduction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycoprotein ligand-Ig. Transplant. Proc. 34:985.
91. Farmer DG, et al. (2005) Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation 80:828-35.
92. Carmody IC, et al. (2004) P-selectin knockout mice have improved outcomes with both warm ischemia and small bowel transplantation. Transplant. Proc. 36:263-4.
93. Ran S, Downes A, Thorpe PE. (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 62:6132-40.
94. Kuypers FA, Larkin SK, Emeis JJ, Allison AC. (2007) Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb. Haemost. 97:478-86.
95. Shen XD, et al. (2007) Diannexin, a novel annexin V homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am. J. Transplant. 7:2463-71.
96. Teoh NC, et al. (2007) Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 133:632-46.
97. Moore C, Shen XD, Gao F, Busuttil RW, Coito AJ. (2007) Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury. Am. J. Pathol. 170:567-77.
98. Hamada T, Fondevila C, Busuttil RW, Coito AJ. (2008) Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology (Baltimore) 47:186-98.
99. Khandoga A, et al. (2006) Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J. Leukocyte Biol. 79:1295-305.
100. + T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J. Clin. Invest. 100:279-89.
101. + T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J. Immunol. 176:6313-22.
102. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J. (2004) Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. 286:G285-93.
103. + to ELR- CXC chemokines affects the lung and liver injury following hepatic ischemia/ reperfusion in the rat. Hepatology (Baltimore) 31:435-45.
104. + T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. Am. J. Physiol. 289:G969-76.
105. Rabb H, et al. (2000) Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279:F525-31.
106. Lang JD Jr, et al. (2007) Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J. Clin. Invest. 117:2583-91.
107. Baskin-Bey ES, et al. (2007) Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am. J. Transplant. 7:218-25.
108. Aldrighetti L, et al. (2006) Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl. 12:941-9.
109. Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. (2003) Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br. J. Surg. 90:17-22.
110. St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. (2003) Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl. 9:144-9.
111. Khan AW, Fuller BJ, Shah SR, Davidson BR, Rolles K. (2005) A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. Ann. Hepatol. 4:121-6.
112. Goggins WC, et al. (2003) A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76:798-802.
113. Bogetti D, et al. (2005) Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin. Transplant. 19:507-11.
114. Ito K, Ozasa H, Sanada K, Horikawa S. (2000) Doxorubicin preconditioning: a protection against rat hepatic ischemia-reperfusion injury. Hepatology (Baltimore) 31:416-9.
115. Shen XD, et al. (2002) CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 74:315-9.
116. Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, Dufour JF. (2002) Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology (Baltimore) 35:1082-92.
117. Berberat PO, et al. (2003) Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 17:1724-6.
118. Ke B, Shen XD, Lassman CR, Gao F, Busuttil RW, Kupiec-Weglinski JW. (2003) Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am. J. Transplant. 3:1076-82.
119. Shen XD, et al. (2003) Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology (Baltimore) 37:296-303.
120. Ke B, et al. (2004) Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury. Mol. Ther. 9:38-45.
121. Shen XD, et al. (2005) Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/ reperfusion injury. Am. J. Transplant. 5:1793-800.
122. Kim YI, Hwang YJ, Song KE, Yun YK, Lee JW, Chun BY. (2002) Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. J. Am. Coll. Surg. 195:41-50.